pharma · COVID-19
Labiana Health
Hipra Human Health S.L.
Hipra Human Health is a pharma organization headquartered in EU. Primary therapeutic focus areas include COVID-19. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from
Company details
- Status
- Public
- HQ
- ES
- Founded
- 1958
- Employees
- 318
- Programs
- 2
- Drugs
- 6
- Patents
- 0
HIPRA-HH-17
Approved · small molecule · COVID-19
HIPRA-HH-17 for COVID-19 is a Approved program (small_molecule) at Hipra Human Health S.L. with 1 ClinicalTrials.gov record(s).
Internal code HIPRA-HH-17
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Hipra Human Health S.L.
- Phase
- Approved
- Modality
- small_molecule
- Indication
- COVID-19
- Status
- active
- Trials
- 1